Your browser doesn't support javascript.
loading
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer.
Manegold, C; van Zandwijk, N; Szczesna, A; Zatloukal, P; Au, J S K; Blasinska-Morawiec, M; Serwatowski, P; Krzakowski, M; Jassem, J; Tan, E H; Benner, R J; Ingrosso, A; Meech, S J; Readett, D; Thatcher, N.
Afiliação
  • Manegold C; Interdisciplinary Thoracic Oncology, Department of Surgery, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany. Electronic address: Prof.Manegold@t-online.de.
  • van Zandwijk N; Bernie Banton Centre, University of Sydney, Sydney, Australia.
  • Szczesna A; 3rd Department, Regional Lung Diseases Hospital, Otwock, Poland.
  • Zatloukal P; 3rd Faculty of Medicine, Charles University, Faculty Hospital Bulovka and Postgraduate Medical Institute, Prague, Czech Republic.
  • Au JSK; Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong.
  • Blasinska-Morawiec M; Department of Proliferative Diseases, Copernicus Memorial Hospital, Lodz.
  • Serwatowski P; Chemotherapy Department, Specialistic Hospital Named After Professor A. Sokolowski, Szczecin-Zdunowo.
  • Krzakowski M; Lung and Thoracic Tumours Department, Maria Sklodowska-Curie Memorial Cancer Centre, Warsaw.
  • Jassem J; Department of Oncology and Radiology, Medical University of Gdansk, Gdansk, Poland.
  • Tan EH; Department of Medical Oncology, National Cancer Centre, Singapore.
  • Benner RJ; Pfizer Global Research and Development, New London, USA.
  • Ingrosso A; Pfizer Global Research and Development, Milan, Italy.
  • Meech SJ; Pfizer Global Research and Development, New London, USA.
  • Readett D; Pfizer Global Research and Development, New London, USA.
  • Thatcher N; Department of Medical Oncology, Christie Hospital, Manchester, UK.
Ann Oncol ; 23(1): 72-77, 2012 Jan.
Article em En | MEDLINE | ID: mdl-21464154

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligodesoxirribonucleotídeos / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligodesoxirribonucleotídeos / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2012 Tipo de documento: Article